Advertisement
News
Subscribe to MDT Magazine News

Stonewedge still stealthy after second $1M round

March 9, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Andover startup Stonewedge Corp. has taken in $1 million from a single, unnamed investor, bringing to $2 million the amount the stealthy wellness technology company has raised.

Contrast Media Reactions Are Allergic, but Minor

March 9, 2011 4:34 am | by Diagnostic Imaging | Comments

Final results of the prospective French CIRTACI trial are in: contrast media for diagnostic imaging are very safe in general, as long as radiologists are vigilant for patients with allergies, asthma, or previous reactions to contrast agents. The vast majority are more itchy than serious.

TOPICS:

Improving on PET: Adding a Blue Glow, Removing a Crystal

March 9, 2011 4:34 am | by Diagnostic Imaging | Comments

PET hybrid technologies are already hot, and two innovations discussed during the final session of ECR 2011 are aimed at making them more even powerful and efficient.

TOPICS:
Advertisement

Photo Release -- PositiveID Corporation Completes Development of Its iglucose(TM) Mobile Health Solution for Real-Time Diabetes Management

March 9, 2011 4:34 am | by PositiveID | Comments

Photo Release -- PositiveID Corporation Completes Development of Its iglucose(TM) Mobile Health Solution for Real-Time Diabetes Management

TOPICS:

Walgreen selling pharmacy benefits ops for $525M

March 9, 2011 3:45 am | by The Associated Press | Comments

Walgreen Cos. says it will sell its pharmacy benefits management business to Catalyst Health Solutions Inc. for $525 million in cash.Walgreen says it is focusing on its drugstore network, which is the largest in the U.S., along with its specialty pharmacy and mail service businesses.The...

Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronie's Disease

March 9, 2011 3:35 am | by Bio-Medicine.Org | Comments

MALVERN, Pa., March 9, 2011 /- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ), a specialty biopharmaceutical company, today announced it has reached the target enrollment for the double-blind placebo-controlled phase III program of XIAFLEX ® for the treatment of Peyronie's disease....

TOPICS:

Jazz Pharmaceuticals to Present at Upcoming Investor Conferences

March 9, 2011 3:34 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., March 8, 2011 /- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that the company will be providing a business update at two upcoming investor conferences:   Kathryn Falberg, the company's chief financial officer, will provide an update at the ROTH 23rd...

TOPICS:

Fluidigm pares 4Q loss as revenue rises

March 9, 2011 2:45 am | by The Associated Press | Comments

SOUTH SAN FRANCISCO, Calif. (AP) — Fluidigm Corp. on Wednesday reported a smaller loss in its final quarter before it conducted its initial public offering.The company makes equipment to control fluids in small volumes for applications such as genetic analysis. It completed its IPO in February,...

Advertisement

IMT adds sixth bond option to its arsenal of hermetic wafer level packaging

March 9, 2011 1:35 am | by I-Micronews | Comments

(BUSINESS WIRE)--IMT, a pioneer in the development and implementation of wafer level packaging, introduced its hermetic gold-to-gold (Au-Au) thermo compression bonding today.

3M Expert Conference Outlines New Approaches to Preventing Surgical Site Infections

March 9, 2011 1:34 am | by RealWire | Comments

"Improving Implementation and Compliance with Infection Control Protocols Is Key"With current data showing that at least 5% of patients undergoing surgery develop a surgical site infection (SSI) and with SSIs comprising up to 20% of all healthcare associated infections1, their prevalence...

TOPICS:

Optics: Mastering bandwidth

March 8, 2011 11:41 pm | by I-Micronews | Comments

Researchers have developed a tunable, low-cost laser device that could help advance fiber-optic communications.

Cubist names Bate as non-exec board chairman

March 8, 2011 10:35 pm | by Mass High Tech: The Journal of New England Technology | Comments

Cubist Pharmaceuticals Inc. has named Kenneth M. Bate as non-executive chair of the company's board. Bate, who takes on the appointment immediately, has been the lead director of the board since mid-2006.

Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents

March 8, 2011 10:34 pm | by Bio-Medicine.Org | Comments

FISHKILL, N.Y., March 9, 2011 /PRNewswire-USNewswire/ -- Nearly half a million patients in New York's Hudson Valley can now call their primary care physician offices patient-centered medical homes, thanks to a Taconic Health Information Network and Community (THINC) project that garnered...

TOPICS:

Inaugural Herbert A. Fleisch ESCEO-IOF Medal is awarded to Professor Gerard Karsenty

March 8, 2011 10:34 pm | by International Osteoporosis Foundation | Comments

The newly created award recognizes outstanding and groundbreaking achievements in basic bone science. It will be presented on March 23rd at  the opening of the European Congress on Osteoporosis & Osteoarthritis in Valencia.

TOPICS:

A Better Disc for Back Repair

March 8, 2011 7:35 pm | by Massachusetts Institute of Technology | Comments

Implants grown from living cells could offer better support and flexibility.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading